This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Feng Wang, PhD
Associate Director and Principal Investigator, Institute of Biophysics at Chinese Academy of Sciences


Feng Wang, PhD, is the associate director and principal investigator at Key Laboratory of Protein and Peptide Therapeutics of Institute of Biophysics, Chinese Academy of Sciences. His research work focuses on developing new methods to identify and design novel antibody and antibody derivatives as therapeutics. Before joining IBP, Dr. Wang worked with Dr. Peter Schultz to establish California Institute for Biomedical Research (CaliBR) in 2012. He was principal investigator in charge of the group of protein therapeutics from 2012 to 2017. His work is currently supported by multiple state funding agencies and was funded by Bill & Melinda Gates Foundation, Juvenile Diabetes Research Foundation (JDRF), Pfizer and Merck & CO.

Dr. Wang got his Ph.D in biochemistry at TAMU in 2007 and did his postdoc research work at The Scripps Research Institute, La Jolla, California.

Agenda Sessions

  • Epitope Directed Antibody Selection